Exercise, Fitness and Tumor Profiling in Breast Cancer Patients (NCT03424915)
Integrative Profiling of Primary Breast Cancer on the Basis of Divergent Exercise Exposure
🩺 Plain-English Summary (8th-Grade Level)
This study is designed to find out how engaging in regular exercise (or not) alters the biology of breast tumors as well as the normal tissue (if available) surrounding the tumor. The investigators hope that findings from this initial study will guide the design of future studies to examine how changes in exercise alter breast tumor biology.
Who can join: Review the eligibility criteria below.
Location: Memorial Sloan Kettering Basking Ridge (Consent and Follow-up) — Basking Ridge, New Jersey
Age range: 21 Years to 80 Years
🧪 Interventions in This Study
- Harvard Health Professionals survey (BEHAVIORAL)
- Blood draw (OTHER)
- CPET Procedures (OTHER)
- stool sample (OTHER)
- Research Tissue sampling (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-up) — Basking Ridge, New Jersey
- Memorial Sloan Kettering Monmouth (Consent and Follow-up) — Middletown, New Jersey
- Memorial Sloan Kettering Bergen (Consent and Follow-up) — Montvale, New Jersey
- Memorial Sloan Kettering Commack (Consent and Follow-up) — Commack, New York
- Memorial Sloan Kettering Westchester (Consent and Follow-up) — Harrison, New York
- Memorial Sloan Kettering Cancer Center (Consent and Follow-up) — New York, New York
- Memorial Sloan Kettering Nassau (Consent and Follow-up) — Uniondale, New York
📞 Contact the Study Coordinator
Phone: (800) 525-2225
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Anniston, Alabama
- [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer — Los Angeles, California
- Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery — Durham, North Carolina
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) — Palo Alto, California
- A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer — Chicago, Illinois
- ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer — Duarte, California
Explore by condition: All Breast Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.